Fulbright/RCSI PhD Award

The Fulbright/RCSI PhD Award is a partnership between the Fulbright U.S. Student Program and the Royal College of Surgeons in Ireland (RCSI) that enables U.S. citizens to complete a fully funded PhD at RCSI over a period of 4 years. RCSI is an innovative, pioneering international health sciences education and research institution dedicated to breakthroughs and service of excellence in human health. The award is part of the StAR PhD programme, which aims to attract high-achieving international students to an efficient four-year structured, fully funded PhD training programme. The programme encourages scientists to develop innovative research projects in RCSI's areas of research strength, including Cancer, Neurological and Psychiatric Disorders, Population Health and Health Services, Biomaterials, Medical Devices and Pharmaceutical Sciences, Surgical Science and Practice, and Vascular Biology. The Fulbright award provides funding for the first 12 months, while RCSI provides fee waivers and funding for the additional 3 years of the 4-year program. Two grants are expected to be awarded in 2026-2027. The maximum value of the award is €170,400 over a maximum of four years.